193 related articles for article (PubMed ID: 34943811)
21. Myelofibrosis: experimental models and human studies.
Taskin AL; Cohen-Solal K; Le Couedic JP; Abina MA; Villeval JL; Debili N; Casadevall N; Vainchenker W; Wendling F
Stem Cells; 1998; 16 Suppl 2():155-64. PubMed ID: 11012187
[TBL] [Abstract][Full Text] [Related]
22. The Role of Megakaryocytes in Myelofibrosis.
Melo-Cardenas J; Migliaccio AR; Crispino JD
Hematol Oncol Clin North Am; 2021 Apr; 35(2):191-203. PubMed ID: 33641863
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA function in megakaryocytes.
Raghuwanshi S; Dahariya S; Musvi SS; Gutti U; Kandi R; Undi RB; Sahu I; Gautam DK; Paddibhatla I; Gutti RK
Platelets; 2019; 30(7):809-816. PubMed ID: 30359163
[TBL] [Abstract][Full Text] [Related]
24. Extramedullary hematopoietic ascitic fluid cytology in myelofibrosis.
Silverman JF
Am J Clin Pathol; 1985 Jul; 84(1):125-8. PubMed ID: 4014072
[TBL] [Abstract][Full Text] [Related]
25. Megakaryopoiesis and Platelet Biology: Roles of Transcription Factors and Emerging Clinical Implications.
Noh JY
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502524
[TBL] [Abstract][Full Text] [Related]
26. [TGF-beta and platelet].
Kogawa K; Mogi Y; Morii K; Takimoto R; Niitsu Y
Rinsho Ketsueki; 1994 Apr; 35(4):370-5. PubMed ID: 8028182
[TBL] [Abstract][Full Text] [Related]
27. Acute myelofibrosis--a leukemia of pluripotent stem cell. A report of three cases and review of the literature.
Amberger DM; Saleem A; Kemp BL; Truong LD
Ann Clin Lab Sci; 1990; 20(6):409-14. PubMed ID: 2073090
[TBL] [Abstract][Full Text] [Related]
28. Endothelial-to-Mesenchymal Transition in Bone Marrow and Spleen of Primary Myelofibrosis.
Erba BG; Gruppi C; Corada M; Pisati F; Rosti V; Bartalucci N; Villeval JL; Vannucchi AM; Barosi G; Balduini A; Dejana E
Am J Pathol; 2017 Aug; 187(8):1879-1892. PubMed ID: 28728747
[TBL] [Abstract][Full Text] [Related]
29. Megakaryocytes and myelofibrosis in gray platelet syndrome.
Caen JP; Deschamps JF; Bodevin E; Bryckaert MC; Dupuy E; Wasteson A
Nouv Rev Fr Hematol (1978); 1987; 29(2):109-14. PubMed ID: 3615193
[TBL] [Abstract][Full Text] [Related]
30. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.
Manshouri T; Verstovsek S; Harris DM; Veletic I; Zhang X; Post SM; Bueso-Ramos CE; Estrov Z
PLoS One; 2019; 14(9):e0222912. PubMed ID: 31569199
[TBL] [Abstract][Full Text] [Related]
31. Pathogenesis and management of idiopathic myelofibrosis.
Reilly JT
Baillieres Clin Haematol; 1998 Dec; 11(4):751-67. PubMed ID: 10640215
[TBL] [Abstract][Full Text] [Related]
32. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders.
Hibbin JA; Njoku OS; Matutes E; Lewis SM; Goldman JM
Br J Haematol; 1984 Jul; 57(3):495-503. PubMed ID: 6743569
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis.
Martyré MC; Romquin N; Le Bousse-Kerdiles MC; Chevillard S; Benyahia B; Dupriez B; Demory JL; Bauters F
Br J Haematol; 1994 Sep; 88(1):9-16. PubMed ID: 7803262
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis.
Gilles L; Arslan AD; Marinaccio C; Wen QJ; Arya P; McNulty M; Yang Q; Zhao JC; Konstantinoff K; Lasho T; Pardanani A; Stein B; Plo I; Sundaravel S; Wickrema A; Migliaccio A; Gurbuxani S; Vainchenker W; Platanias LC; Tefferi A; Crispino JD
J Clin Invest; 2017 Apr; 127(4):1316-1320. PubMed ID: 28240607
[TBL] [Abstract][Full Text] [Related]
35. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
[TBL] [Abstract][Full Text] [Related]
36. Deficient in vitro megakaryocytopoiesis and decreased in vivo platelet turnover in children and young adults with chronic thrombocytopenia.
Parker RI; Siegel RS; Ratajczak MZ; Gewirtz AM
J Pediatr Hematol Oncol; 1998; 20(3):196-201. PubMed ID: 9628429
[TBL] [Abstract][Full Text] [Related]
37. The marrow stem cell niche in normal and malignant hematopoiesis.
Kaushansky K; Zhan H
Ann N Y Acad Sci; 2020 Apr; 1466(1):17-23. PubMed ID: 30767234
[TBL] [Abstract][Full Text] [Related]
38. Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives.
Barosi G; Rosti V; Gale RP
Leukemia; 2023 Apr; 37(4):725-727. PubMed ID: 36871061
[TBL] [Abstract][Full Text] [Related]
39. Regeneration of megakaryocytopoiesis and thrombopoiesis in vitro from X-irradiated human hematopoietic stem cells.
Kashiwakura I; Inanami O; Abe Y; Satoh K; Takahashi TA; Kuwabara M
Radiat Res; 2006 Aug; 166(2):345-51. PubMed ID: 16881735
[TBL] [Abstract][Full Text] [Related]
40. Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes.
Castro-Malaspina H; Moore MA
Nouv Rev Fr Hematol (1978); 1982; 24(4):221-6. PubMed ID: 6292827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]